REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,189 | -81.5% | 13 | -100.0% | 0.00% | -100.0% |
| Q4 2022 | $11,829 | -99.9% | 69,863 | +11.2% | 0.08% | -11.8% |
| Q3 2022 | $11,753,000 | +15.9% | 62,811 | +0.6% | 0.08% | +21.4% |
| Q2 2022 | $10,144,000 | -11.6% | 62,463 | +2.4% | 0.07% | +2.9% |
| Q1 2022 | $11,476,000 | -27.8% | 61,013 | +1.7% | 0.07% | -26.1% |
| Q4 2021 | $15,893,000 | -8.4% | 60,008 | -0.1% | 0.09% | -17.9% |
| Q3 2021 | $17,354,000 | +33.0% | 60,051 | -8.1% | 0.11% | +31.8% |
| Q2 2021 | $13,045,000 | -3.6% | 65,350 | -6.2% | 0.08% | -10.5% |
| Q1 2021 | $13,538,000 | +3.2% | 69,637 | +1.7% | 0.10% | -21.5% |
| Q4 2020 | $13,123,000 | +32.3% | 68,480 | +1.9% | 0.12% | -4.0% |
| Q3 2020 | $9,919,000 | -10.5% | 67,229 | -25.0% | 0.13% | -13.1% |
| Q2 2020 | $11,083,000 | +30.7% | 89,657 | +2.0% | 0.14% | +1.4% |
| Q1 2020 | $8,482,000 | +2.0% | 87,864 | -2.3% | 0.14% | +53.8% |
| Q4 2019 | $8,316,000 | – | 89,905 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |